Summit Therapeutics Inc

Groundbreaking Lung Cancer Drug Reduces Death Risk by 34% in Controversial Late-Stage Trial in China

An experimental lung cancer drug called ivonescimab, developed by Akeso and Summit Therapeutics, has shown promise in clinical trials. Recent ... Read more